Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16702147 | 0.85 | HRH3 (0.57) | HRH3KCNH2 | |
| SCHEMBL2821556 | 0.85 | HRH3 (0.57) | HRH3KCNH2 | |
| SCHEMBL737639 | 0.84 | HRH3 (0.63) | HRH3KCNH2 | |
| SCHEMBL2819889 | 0.82 | HRH3 (0.55) | HRH3 | |
| SCHEMBL4464014 | 0.81 | HRH3 (0.68) | HRH3KCNH2 | |
| SCHEMBL4221612 | 0.80 | HRH3 (0.52) | HRH3KCNH2 | |
| SCHEMBL3272606 | 0.80 | HRH3 (0.57) | HRH3 | |
| SCHEMBL508364 | 0.80 | CSNK2A1 (0.56) | HRH3 | |
| SCHEMBL17533980 | 0.80 | HRH3 (0.58) | HRH3KCNH2 | |
| SCHEMBL5019001 | 0.80 | ST14 (0.48) | HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2694492-B1 | NOVEL COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | SUVEN LIFE SCIENCES LTD (IN) | 2015-07-29 | — | — | EP | disclosed |
| US-9079888-B2 | Compounds as histamine H3 receptor ligands | SUVEN LIFE SCIENCES LIMITED (IN) | 2015-07-14 | — | — | US | disclosed |
| US-20140135304-A1 | NOVEL COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | SUVEN LIFE SCIENCES LIMITED (IN) | 2014-05-15 | — | — | US | disclosed |
| EP-2694492-A1 | NOVEL COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | Suven Life Sciences Limited (IN) | 2014-02-12 | — | — | EP | disclosed |
| WO-2012114348-A1 | NOVEL COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | SUVEN LIFE SCIENCES LIMITED (IN) | 2012-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140135304-A1 | NOVEL COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | HRH3, HRH4, HRH1 | HRH3 1/4885KCNH2 643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.